冠心病合并高血压患者降压达标及降压药物使用情况研究  

Investigation on the standard of blood pressure reduction and the use of antihypertensive drugs in patients with coronary heart disease and hypertension

作　　者：傅升华 FU Sheng-hua(Department of Internal Medicine of Taian Maternal and Child Health Hospital,Taian Shandong 271000,China)

机构地区：[1]泰安市妇幼保健院内科,山东泰安271000

出　　处：《中国卫生工程学》2020年第5期660-662,共3页Chinese Journal of Public Health Engineering

基　　金：山东省医药卫生科技发展计划项目(2017WS0326)。

摘　　要：目的研究冠心病合并高血压患者降压达标及降压药物使用情况。方法选取2018年1月至12月本院收治的冠心病合并高血压患者345例。问卷调查方式收集患者性别、年龄、降压药物使用情况;现场测量患者血压,根据相关指南中的降压目标值进行分析。结果 345例冠心病合并高血压患者中,血压<130/80 mm Hg的达标率为17.10%;随着降压目标值的升高,达标率明显增加,血压<150/90 mm Hg的达标率为51.30%。不同年龄段患者各降压目标值的达标率之间比较差异均有统计学意义(均P<0.01)。女性冠心病合并高血压患者各降压目标值的达标率均明显高于男性患者,差异均有统计学意义(均P<0.05)。冠心病合并高血压患者中,血管紧张素受体拮抗剂(ARB)或血管紧张素转化酶抑制剂(ACEI)使用率最高,其次为钙通道阻断剂(CCB)。其中联合用药256例(74.20%)。结论冠心病合并高血压患者各降压目标值的达标率均偏低,其中男性、高龄患者达标率更低;降压药物以ARB或ACEI为主,其次为CCB,多为联合降压治疗。Objective To understand the standard of blood pressure reduction and the use of antihypertensive drugs in patients with coronary heart disease and hypertension.Methods 345 patients with coronary heart disease and hypertension were selected from January to December 2018.Questionnaire survey was used to collect the patients’gender,age and use of antihypertensive drugs;blood pressure was measured on site and analyzed according to the target value of antihypertensive in relevant guidelines.Results In 345 patients with coronary heart disease and hypertension,the rate of reaching the standard of blood pressure<130/80 mmHg was 17.10%.With the increase of the target value of reducing blood pressure,the rate of reaching the standard increased significantly.The rate of reaching the standard of blood pressure<150/90 mm Hgwas 51.30%. There was a significant difference in the rate of reaching the blood pressure target among patients of differentages ( P<0.01);with the increase of age,the rate of reaching the blood pressure target decreased significantly. The targetrate of different blood pressure reduction in female patients with coronary heart disease and hypertension was significantlyhigher than that in male patients ( P<0.05) . Among the patients with coronary heart disease and hypertension,the use rateof ARB or ACEI was the highest,followed by CCB. Among them,256 cases ( 74.20%) were treated with combinationdrugs.Conclusion The target rate of each blood pressure reduction in patients with coronary heart disease and hypertensionis low. The main antihypertensive drugs are ARB or ACEI,followed by CCB,mostly combined antihypertensive therapy.

关 键 词：冠心病 高血压 降压达标率 降压药物 

分 类 号：R541.4[医药卫生—心血管疾病] R544.1[医药卫生—内科学]